Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 55Neoplasms, Plasma Cell 22Central Nervous System Neoplasms 10Prostatic Neoplasms 9Glioblastoma 9Recurrence 8Melanoma 8Brain Neoplasms 8Neoplasms 7Gliosarcoma 7Carcinoma, Non-Small-Cell Lung 7Sarcoma 6Leukemia 6Carcinoma, Hepatocellular 6Waldenstrom Macroglobulinemia 5Myeloproliferative Disorders 5Lung Neoplasms 5Leukemia, Lymphocytic, Chronic, B-Cell 5Glioma 5Colorectal Neoplasms 5Myelodysplastic-Myeloproliferative Diseases 4Myelodysplastic Syndromes 4Lymphoma 4Liver Neoplasms 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Kidney Neoplasms 4Carcinoma, Renal Cell 4Lymphoma, Mantle-Cell 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Chronic 3

Interventions

Tacrolimus 38Cyclophosphamide 27Methotrexate 26Mycophenolic Acid 21Cyclosporine 21Busulfan 21fludarabine phosphate 20Antilymphocyte Serum 20Melphalan 15fludarabine 13Sirolimus 13Methylprednisolone 13Peripheral Blood Stem Cell Transplantation 12Whole-Body Irradiation 10thymoglobulin 9Stem Cell Transplantation 8Radiotherapy 7ruxolitinib 6Thiotepa 6Rituximab 6Granulocyte Colony-Stimulating Factor 6Prednisone 5Hematopoietic Stem Cell Transplantation 5Filgrastim 5Alemtuzumab 5Transplantation 4Etoposide 4Cytarabine 4Cord Blood Stem Cell Transplantation 4Pentostatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Graft vs Host Disease × Thalidomide × Clear all
NCT00003894 2011-03-07

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

Roswell Park Cancer Institute

Phase 2 Completed
36 enrolled

Graft vs Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡